BELLUS Health Inc

BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization related disorders. The Company product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.